⌘K

Login Start Free

Home/Filings/4/0001104659-19-014626

4//SEC Filing

Truong Vu 4

Accession 0001104659-19-014626

CIK 0001614067other

View on SEC.gov Company Profile

Filed

Mar 12, 8:00 PM ET

Accepted

Mar 13, 6:30 PM ET

Size

5.1 KB

Accession

0001104659-19-014626

Insider Transaction Report

Form 4

Period: 2019-02-20

Aridis Pharmaceuticals, Inc.ARDS

DirectorCEO, CSO, Director10% Owner

Transactions

Award
Stock Options
2019-02-20+200,000→ 316,861 total
Exercise: $8.46Exp: 2029-02-20→ Common Stock (200,000 underlying)

Footnotes (1)

[F1]The Stock Options vest in equal installments over 48 months, beginning on March 20, 2019.

Documents

1 file

4
a4.xmlPrimary
4

Issuer

Aridis Pharmaceuticals, Inc.

CIK 0001614067

Entity typeother

Related Parties

1

filerCIK 0001749993

Filing Metadata

Form type: 4
Filed: Mar 12, 8:00 PM ET
Accepted: Mar 13, 6:30 PM ET
Size: 5.1 KB

View on SEC.gov